Bortezomib Induced Hepatitis B Reactivation

Background. It has recently been reported that hepatitis B (HBV) reactivation often occurs after the use of rituximab and stem cell transplantation in patients with lymphoma who are hepatitis B surface antigen (HBsAg) negative. However, clinical data on HBV reactivation in multiple myeloma (MM) is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Salwa, Jhaj, Ruby, Ahsan, Samira, Ahsan, Muhammad, Bloom, Robert E., Jafri, Syed-Mohammed R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021848/
https://www.ncbi.nlm.nih.gov/pubmed/24876846
http://dx.doi.org/10.1155/2014/964082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021848/
https://www.ncbi.nlm.nih.gov/pubmed/24876846
http://dx.doi.org/10.1155/2014/964082

Ejemplares similares